Top Markets
#1 Islamic Coin Islamic Coin +151.45%
#2 DOVU DOVU +49.94%
#3 Velvet Velvet +41.51%
#4 Black Phoenix Black Phoenix +34.92%
#5 Palladium Network Palladium Network +21.70%
#6 Akedo Akedo +19.80%
#7 Fake World Assets Fake World Assets +19.72%
#8 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.99%
#9 DoubleZero DoubleZero +18.67%
#10 Not in Employment, Education, or Training Not in Employment, Education, or Training +13.01%
Coin of the day
Islamic Coin Islamic Coin
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
MGC Pharmaceuticals Limited MGC Pharmaceuticals Limited

MGC Pharmaceuticals Limited

MXC
Classifica tra le azioni #39836
MGC Pharmaceuticals Limited, an Australian biopharmaceutical firm established... MGC Pharmaceuticals Limited, an Australian biopharmaceutical firm established in West Perth in 2014, focuses on the worldwide development and distribution of plant-derived medicines. Its product portfolio encompasses both medicinal cannabis solutions and other botanical therapeutics. The company's key investigational treatments include CimetrA, currently in Phase III clinical trials for the symptomatic relief of early-stage COVID-19; CannEpil, a cannabis-based therapy undergoing Phase IIb studies for drug-resistant epilepsy; and CogniCann, which is in Phase II clinical development for alleviating dementia symptoms. Beyond these core candidates, MGC Pharmaceuticals also supplies the ArtemiC range, various other cannabinoid-infused products, and non-pharmaceutical items. Additionally, the company provides expert consulting services, particularly in clinical research. The company was previously named Erin Resources Limited before adopting its current identity, MGC Pharmaceuticals Limited, in December 2015.
Prezzo delle azioni
$0.27239819
Ultima sincronizzazione: 2024-04-29
Capitalizzazione di mercato
$330.42K
Variazione (1 giorno)
0.52%
Variazione (1 anno)
0.00%
Paese
AU
Scambia MGC Pharmaceuticals Limited (MXC)

Categoria

Healthcare
Utile per MGC Pharmaceuticals Limited (MXC)
Utile nel 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di MGC Pharmaceuticals Limited, gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, uguale a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Storico degli utili di MGC Pharmaceuticals Limited dal 2026 al 2026
Utile alla fine di ogni anno
Anno Utile Cambia
Non abbastanza dati per le date fornite.
Utile per aziende simili o concorrenti
Azienda Utile Differenza negli utili Il paese
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
- -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
- -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
- -
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
- -
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
$1.76B -
IN